TREATMENT OF SEVERELY PAINFUL DIABETIC NEUROPATHY WITH AN ALDOSE REDUCTASE INHIBITOR: RELIEF OF PAIN AND IMPROVED SOMATIC AND AUTONOMIC NERVE FUNCTION
Open Access
- 1 October 1983
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 322 (8353) , 758-762
- https://doi.org/10.1016/s0140-6736(83)92296-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic ratsDiabetologia, 1983
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983
- The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic ratsDiabetes, 1982
- Continuous Subcutaneous Insulin Infusion in the Management of Painful Diabetic NeuropathyDiabetes Care, 1982
- Clinical trial of an aldose reductase inhibitor in diabetic neuropathyDiabetes, 1981
- Effect of an Aldose Reductase Inhibitor on Diabetic Peripheral NeuropathyArchives of Neurology, 1981
- Diabetic Neuropathy—New Concepts of Its EtiologyDiabetes, 1979
- Hyperglycemia, Polyol Metabolism, and Complications of Diabetes MellitusAnnual Review of Medicine, 1975
- The Sorbitol Pathway and the Complications of DiabetesNew England Journal of Medicine, 1973
- Formation of Polyols by the Lens of the Rat with ‘Sugar’ CataractNature, 1959